The Group’s is proof of our ability to meet the daily challenges in the markets in which we operate and of our determination to steadfastly pursue important medium- to long-term goals.
The diversification of the Group’s companies, the investments in research and development, and the strength of our brands and people give us the drive and ambition to want to grow further, playing an increasingly important role in both the medical and industrial sectors.
8
We have always considered our research and development division a key strategic choice.
26
Today, El.En. S.p.a. is the leader of a group of companies divided into 3 sectors: medical, industrial, conservation.
692 million
+2,8%
40+
Our company was established in 1981 in Florence and has, since then, steadily evolved to become a reference point in the field of lasers for medicine, industry, and restoration.
91 million
The results we have achieved confirm the soundness of our business model, which makes it possible for us to combine economic growth and financial solidity with the principles of social and environmental sustainability, to represent a model of excellence. The positive growth trend and the trust of our stakeholders spur us on to continue looking ahead, innovating with passion, remaining faithful to the values and principles that have always marked our path, and making our contribution to building a better future for all.
The group’s organisation into numerous companies has enabled its growth, making it one of the most important players on the market. Each company maintains a specific characterisation by product type and segmentation, with independent brands and distribution networks.
Continuing the development policy already outlined, thanks to investments in research and development and the constant improvement of its worldwide distribution networks, the Group has been able to improve its positioning in both the medical and industrial sectors.
The know-how of our people, whose skills, abilities, and dedication are the main strength of our business, which always requires a great commitment of multidisciplinary teams to successfully meet the challenges that the technological frontier and fast-changing markets pose to us on a daily basis.
The results we have achieved and the trust of our stakeholders spur us on to continue looking ahead, innovating with passion, remaining faithful to the values and principles that have always marked our path, and making our contribution to building a better future for all and the constant commitment of multidisciplinary teams, to successfully meet the challenges that the technological frontier and rapidly evolving markets pose to us on a daily basis. The ability to innovate and pursue excellence depends on the people and employees involved in all activities and is the result of the specialisation, skills and passion that characterise all the people working in the Group.
We are aware of how important sustainability issues are for all our stakeholders and in particular for investors and their investment criteria and analyses. Where the Group is concerned, sustainability is of strategic importance to the extent that it is now integrated into the business model, which combines financial solidity and medium- to long-term economic growth with the principles of social and environmental sustainability. Ethics, empowerment of people, environmental protection, and commitment to research and development to guarantee quality and increasingly high-performance products, represent the road travelled to date towards being an innovative, sustainable, and successful company.
The results achieved within our sectors are the fruit of a long-term strategy that has seen the breadth of the offer and the ability to segment certain markets as the winning choice to maximise the Group’s overall share. Each company has maintained its own specific characterisation in terms of product type and segmentation, with brands and distribution networks independent of the other companies, constituting a true business unit and at the same time enjoying the cross-fertilisation of each core research unit on the others. This strategy, albeit more complex to manage, has made it possible for the Group to grow, making it one of the most important concerns on the market as a whole.
Read more
The core of our strategy remains our constant commitment to research and development, which is the very essence of our Group: a commitment both from a technical point of view, aimed at launching new products, and from a documental and clinical point of view, in order to obtain the necessary certifications to sell our systems worldwide. The breadth of the product range offered and the ability to continuously innovate it to conform to market requirements or, even better, to create new ones, are our critical success factors: every year the product range is expanded and innovated, both in the medical and industrial sectors.
Read more